A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare single-dose oral bioavailability of acetaminophen 650
mg extended release geltabs (containing acetaminophen 650 mg) of OHM Laboratories, USA
(subsidiary of Ranbaxy) with Tylenol extended release geltabs (containing acetaminophen 650
mg) of Mc Neil, Consumer & Specialty Pharmaceuticals, U.S.A in healthy, adult, male human
subjects under fed condition.